Showing results (251-260 of 260) with videos related to

Sort By:
Pageof 26
You have reached the last page of results.This site can display upto 260 results.
Blood|July 16, 2005
CD molecules 2005: human cell differentiation moleculesHeddy Zola, Bernadette Swart, Ian Nicholson, et al.
Cell Reports|September 26, 2024
BTN2A1 targeting reprograms M2-like macrophages and TAMs via SYK and MAPK signalingClément Kerneur, Etienne Foucher, Jaime Guillén Casas, et al.
Frontiers in Immunology|June 15, 2017
Natural Killer Defective Maturation Is Associated with Adverse Clinical Outcome in Patients with Acute Myeloid LeukemiaAnne-Sophie Chretien, Cyril Fauriat, Florence Orlanducci, et al.
The Journal of Clinical Investigation|June 3, 2020
γ9δ2T cell diversity and the receptor interface with tumor cellsAnna Vyborova, Dennis X Beringer, Domenico Fasci, et al.
Cancer Immunology Research|March 17, 2021
Neutral Sphingomyelinase 2 Heightens Anti-Melanoma Immune Responses and Anti-PD-1 Therapy EfficacyAnne Montfort, Florie Bertrand, Julia Rochotte, et al.
Mabs|December 18, 2014
Inhibitors of SRC kinases impair antitumor activity of anti-CD20 monoclonal antibodiesMagdalena Winiarska, Kamil Bojarczuk, Beata Pyrzynska, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 29, 2021
High-dimensional mass cytometry analysis of NK cell alterations in AML identifies a subgroup with adverse clinical outcomeAnne-Sophie Chretien, Raynier Devillier, Samuel Granjeaud, et al.
Cancers|January 28, 2021
Quantification of Immune Variables from Liquid Biopsy in Breast Cancer Patients Links Vδ2+ γδ T Cell Alterations with Lymph Node InvasionStéphane Fattori, Laurent Gorvel, Samuel Granjeaud, et al.
Cancer Research|November 9, 2012
PD-1-expressing tumor-infiltrating T cells are a favorable prognostic biomarker in HPV-associated head and neck cancerCécile Badoual, Stéphane Hans, Nathalie Merillon, et al.
Cancer Research Communications|August 18, 2023
Activating Inducible T-cell Costimulator Yields Antitumor Activity Alone and in Combination with Anti-PD-1 Checkpoint BlockadeSapna Yadavilli, Jeremy D Waight, Sara Brett, et al.
Pageof 26